|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
FY2020
12 months to Mar 31, 2020
|
FY2019
12 months to Mar 31, 2019
|
FY2018
12 months to Mar 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income / (loss) | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Loss / (gain) on disposal of property, plant and equipment | |||||
| Write-down of inventories | |||||
| Write off of property, plant and equipment | |||||
| Change in cash surrender value of life insurance contract | |||||
| Change in fair value of financial instruments | |||||
| Dividend income from financial instruments at fair value | |||||
| Coupons received from financial instruments at amortized cost | |||||
| Loss / (gain) from sale of financial instruments at fair value | |||||
| Loss from redemption of financial instruments at amortized cost | |||||
| Interest expense | |||||
| (Increase) / decrease in deferred tax asset | |||||
| Impairment on financial instruments at amortized cost | |||||
| Changes in assets and liabilities: | |||||
| Trade receivables | |||||
| Other receivables, deposits and prepayments | |||||
| Inventories | |||||
| Right-of-use assets | |||||
| Deferred tax asset | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Accrued charges and deposits | |||||
| Refund liabilities | |||||
| Payable to affiliated parties | |||||
| Income tax liabilities | |||||
| Lease liabilities | |||||
| Long-term deposit received | |||||
| Long-term loan | |||||
| Net cash provided by / (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Proceeds from disposal of property, plant and equipment | |||||
| Acquisition of property, plant and equipment | |||||
| Acquisition of financial instruments at fair value | |||||
| Acquisition of financial instruments at amortized cost | |||||
| Coupons received from financial instruments at amortized cost | |||||
| Proceeds from sale of financial instruments at fair value | |||||
| Proceeds from redemption of financial instruments at amortized cost | |||||
| Dividends received from financial instruments at fair value | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Finance lease payments | |||||
| Advance from notes payable | |||||
| Repayment of notes payable | |||||
| Advance from bank loans | |||||
| Repayment of bank loans | |||||
| Payment to affiliated party | |||||
| Stock repurchase | |||||
| Proceeds from options exercised | |||||
| Advance from long-term loan | |||||
| Net cash generated / (used in) from financing activities | |||||
| Net increase / (decrease) in cash and cash equivalents | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income tax | |||||
Loading...
